Non-alcoholic fatty liver disease develops when fat builds up in liver cells without heavy alcohol use, and the primary driver in most cases is insulin resistance tied to metabolic dysfunction. About one in three adults worldwide now has some degree of fatty liver, making it the most common chronic liver condition on the planet. The causes range from dietary patterns and genetics to hormonal imbalances and even certain medications, but they almost all converge on the same problem: the liver accumulates more fat than it can process.
The condition was recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD) to better reflect what actually causes it. Under the updated definition, a diagnosis requires both fat in the liver and at least one metabolic risk factor, such as excess body weight, high blood sugar, elevated blood pressure, high triglycerides, or low HDL cholesterol. The name change matters because it shifts the focus from what fatty liver is not (alcohol-related) to what it actually is: a metabolic disease.
Insulin Resistance Is the Central Driver
Insulin normally tells the liver to stop producing glucose and to start converting excess energy into fat. When your cells become resistant to insulin, something paradoxical happens: the liver loses its ability to control blood sugar, but it keeps making fat at full speed, or even faster. This selective failure means glucose floods your bloodstream while fat quietly accumulates inside liver cells.
The process is called de novo lipogenesis, which simply means the liver is manufacturing new fat from scratch rather than just storing fat from your diet. In an insulin-resistant state, this fat production runs unchecked. At the same time, insulin resistance in fat tissue elsewhere in the body causes those cells to release more fatty acids into the bloodstream, which the liver then absorbs. So the liver gets hit from two directions: it’s making more fat internally while also receiving a larger load of fat from the rest of the body.
How Diet Fuels Liver Fat
Not all calories contribute equally to liver fat. Fructose, the sugar found in table sugar, high-fructose corn syrup, fruit juice, and sweetened beverages, is processed almost entirely by the liver. Unlike glucose, which your muscles and brain readily use for energy, fructose goes straight to liver cells and activates the molecular machinery for fat production. It switches on specific enzymes that convert carbohydrates into fatty acids, essentially turning sugar into stored liver fat.
Research in children with fatty liver disease illustrates this clearly. Adolescents with the more severe inflammatory form of the disease consumed roughly 10 more teaspoons of added sugar per day than children without the condition. The extra calories came specifically from sweetened beverages, not from fruit. Clinicians treating pediatric fatty liver report that it’s common for affected children to drink two to three sugary beverages daily, including soda, sweet tea, juice, and sports drinks. Notably, the issue isn’t just how much children eat overall. It’s how their livers metabolize sugar differently, making some kids more vulnerable to fat accumulation than others at similar calorie intakes.
A diet high in refined carbohydrates and saturated fat compounds the problem. These foods elevate blood sugar and triglycerides, worsen insulin resistance, and provide the raw materials the liver converts into stored fat.
Genetics Play a Larger Role Than Most People Realize
A gene called PNPLA3 is one of the strongest known genetic risk factors for fatty liver. This gene produces a protein involved in fat processing within liver cells. A common variant of PNPLA3 (called I148M) impairs the liver’s ability to break down stored fat, causing lipid droplets to accumulate.
The effect follows a dose pattern depending on which version you inherit from each parent. Carrying one copy of the risk variant raises your odds of fatty liver by about 1.76 times. Carrying two copies increases the risk 3.3-fold compared to people with neither copy. Population studies show that roughly half of people carry at least one copy of the risk variant, though rates vary by ethnicity. Hispanic populations carry the variant more frequently, which partly explains the higher rates of fatty liver in that group.
PNPLA3 isn’t the whole story. Several other gene variants affect how the liver handles fat storage and export, and researchers continue to identify new ones. But genetics alone rarely cause fatty liver without metabolic or dietary triggers layered on top.
Your Gut Bacteria Affect Your Liver
The liver receives blood directly from the intestines through the portal vein, which means everything your gut produces or leaks gets first-pass exposure to liver cells. When the balance of gut bacteria shifts in unhealthy directions, the liver pays a price.
People with fatty liver disease tend to have higher levels of certain bacteria, particularly a type of E. coli that produces alcohol as a metabolic byproduct. This endogenous alcohol production means your liver can be exposed to low levels of alcohol even if you never drink, contributing to inflammation and fat buildup. Studies have found measurably higher blood alcohol levels in people with the inflammatory form of fatty liver compared to those without it, entirely from gut-produced alcohol.
Gut bacteria also generate other compounds that reach the liver and trigger damage. Some bacterial strains produce a bile acid called deoxycholic acid in response to high-fat diets, which promotes liver inflammation. Others produce branched-chain fatty acids linked to worsening insulin resistance. Meanwhile, people with fatty liver tend to have fewer of the beneficial bacteria, particularly species in the Lachnospiraceae and Ruminococcaceae families, that help maintain gut barrier integrity and produce protective short-chain fatty acids.
When the gut barrier weakens, bacterial fragments leak into the portal blood and activate inflammatory pathways in the liver. This is one of the key mechanisms that pushes simple fat accumulation toward the more dangerous inflammatory stage.
Thyroid and Hormonal Connections
Thyroid hormones regulate how quickly the liver burns fat for energy. In hypothyroidism, reduced levels of active thyroid hormone slow down fat burning inside liver cells, causing triglycerides and toxic fat byproducts to accumulate. This fat buildup then worsens insulin resistance, which in turn stimulates even more fat production, creating a self-reinforcing cycle.
The connection is strong enough that thyroid function testing is often part of the workup when fatty liver is discovered. Even subclinical hypothyroidism, where thyroid levels are only slightly off, has been associated with increased liver fat. Other hormonal conditions that affect fat metabolism, including polycystic ovary syndrome and growth hormone deficiency, also increase the risk of developing fatty liver through similar mechanisms of impaired fat processing and heightened insulin resistance.
Medications That Cause Liver Fat Buildup
Certain prescription drugs can cause or worsen fatty liver as a side effect. These medications interfere with the liver’s ability to burn fat, export it, or avoid toxic fat accumulation.
- Amiodarone (a heart rhythm medication) directly disrupts fat burning in liver cells and is one of the most well-documented drug causes of fatty liver.
- Valproic acid (a seizure and mood stabilizer) impairs the liver’s ability to break down fatty acids for energy.
- Tamoxifen (used in breast cancer treatment) alters fatty acid transport and metabolism in the liver.
- Methotrexate (used for autoimmune conditions) can promote or aggravate fat accumulation, especially in people who already have metabolic risk factors.
- Corticosteroids promote insulin resistance and fat redistribution, increasing liver fat with prolonged use.
- Certain older antiretroviral drugs used in HIV treatment can severely impair the liver’s energy-producing structures, leading to rapid fat accumulation.
Some of these drugs carry low risk on their own but can tip the balance in someone who already has underlying metabolic dysfunction. Others, particularly the older antiretroviral drugs, can cause fatty liver even in otherwise healthy individuals and may progress to inflammation and scarring.
Why Some People Progress and Others Don’t
Most people with fatty liver never develop serious liver damage. Simple fat accumulation, while not ideal, is relatively stable. The danger comes when inflammation sets in, a stage now called metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH). From there, repeated cycles of inflammation can lead to scarring (fibrosis) and eventually cirrhosis.
What determines who progresses? It’s typically a combination of the factors described above stacking on top of each other. Someone with genetic susceptibility who also has insulin resistance, a high-sugar diet, disrupted gut bacteria, and an underactive thyroid faces a much steeper risk than someone with just one of those factors. The liver can handle a certain amount of fat, but when multiple pathways are simultaneously pushing fat in and blocking fat from leaving, the tipping point arrives faster. This is why fatty liver is increasingly understood not as a single disease with a single cause, but as a condition where several metabolic failures converge on one organ.